| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2075 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1495 | 2018 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 559 | 2014 |
| A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin MG Swain, MY Lai, ML Shiffman, WGE Cooksley, S Zeuzem, DT Dieterich, ... Gastroenterology 139 (5), 1593-1601, 2010 | 514 | 2010 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 413 | 2014 |
| Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment F Piñero, M Dirchwolf, MG Pessôa Cells 9 (6), 1370, 2020 | 338 | 2020 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 309 | 2022 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 273 | 2014 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 164 | 2022 |
| Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic MG Pessoa, NA Terrault, J Detmer, J Kolberg, M Collins, HM Hassoba, ... Hepatology 27 (3), 877-880, 1998 | 160 | 1998 |
| Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile HP Cotrim, ER Parise, CPMS Oliveira, N Leite, A Martinelli, J Galizzi, ... Annals of hepatology 10 (1), 33-37, 2016 | 121 | 2016 |
| The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease N Mendez-Sanchez, M Arrese, A Gadano, CP Oliveira, E Fassio, JP Arab, ... The Lancet Gastroenterology & Hepatology 6 (1), 65-72, 2021 | 109 | 2021 |
| Disease burden of chronic hepatitis C in Brazil PRA Ferreira, CE Brandão-Mello, C Estes, FL Gonçales, HSM Coelho, ... Brazilian Journal of Infectious Diseases 19 (4), 363-368, 2015 | 100 | 2015 |
| Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation MG Pessoa, N Bzowej, M Berenguer, Y Phung, M Kim, L Ferrell, ... Hepatology 30 (6), 1513-1520, 1999 | 95 | 1999 |
| International liver transplantation society consensus statement on hepatitis C management in liver transplant candidates NA Terrault, GW McCaughan, MP Curry, E Gane, S Fagiuoli, JYY Fung, ... Transplantation 101 (5), 945-955, 2017 | 86 | 2017 |
| Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index … TG Ragazzo, D Paranagua-Vezozzo, FR Lima, DF de Campos Mazo, ... Clinics 72, 516-525, 2017 | 86 | 2017 |
| Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation MG Pessoa, NA Terrault, LD Ferrell, JP Kim, J Kolberg, J Detmer, ... Hepatology 25 (5), 1266-1270, 1997 | 70 | 1997 |
| Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy MG Pessôa, B Gazzard, AK Huang, CE Brandão-Mello, I Cassetti, ... Aids 22 (14), 1779-1787, 2008 | 69 | 2008 |
| Histological response to pegIFNα-2a (40KD) plus ribavirin in HIV–hepatitis C virus co-infection E Lissen, N Clumeck, R Sola, M Mendes-Correa, J Montaner, M Nelson, ... Aids 20 (17), 2175-2181, 2006 | 65 | 2006 |
| Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach AS Benzaken, R Girade, E Catapan, GFM Pereira, EC Almeida, ... Brazilian Journal of Infectious Diseases 23, 182-190, 2019 | 62 | 2019 |
